Professor of Microbiology & Immunology
Director of MCB Program
TCC Associate Member
rfgarry@tulane.edu
Lab homepage: http://www.Tulane.EDU:80/~dmsander/GarryHomePage.html
Faculty listing on the Microbiology website:
http://www.som.tulane.edu/departments/microbiology/garry.htm
(504) 988-2027, (504) 988-1994 fax
1430 Tulane Ave., Box SL-38, New Orleans, LA 70112-2699

Dr. Garry received his B.S in Life Sciences with a minor in Chemistry from Indiana State University in 1978. He then carried out doctoral studies in Microbiology at the University of Texas at Austin under the direction of Dr. Marilynn R.F. Waite and received his Ph.D. in 1978. His dissertation was entitled: "Intracellular sodium and potassium and the regulation of gene expression in virus-infected and virus-transformed chick cells." He carried out postdoctoral research in virology at UT Austin under the mentorship of Dr. Henry R. Bose, Jr. In 1983 Dr. Garry was appointed Assistant Professor of Microbiology and Immunology at Tulane University School of Medicine in New Orleans, Louisiana. In 1985 he was Visiting Professor of Pathology at the University of Southern California working with Dr. Suraiya Rasheed. Dr. Garry spent 1991 as a Visiting Professor of Molecular Biology at the University of Hamburg working with Dr. Gebhard Koch. Since 1993 he has been Professor of Microbiology and Immunology at Tulane Medical School. Dr. Garry has published over 100 papers in the area of retrovirology. Research in the Garry Laboratory focuses on a number of aspects of retroviral pathogenesis. Investigations have found that HIV induces a number of defects in plasma membrane ion transport, which could account for the loss of CD4+ T-cells in AIDS patients. Another research interest is the molecular characterization of an isolate of HIV from a patient who died of AIDS in 1969. This is the earliest confirmed case of AIDS in the United States. In addition, the lab has discovered a retrovirus named human intracisternal A-type retroviral particle (HIAP), which appears to be involved in systemic autoimmune diseases and idiopathic CD4 T-lymphocytopenia. More recently, the lab obtained evidence for the existance of a human endogenous retrovirus named human mammary tumor virus (HMTV), which is a close homolog of a virus which causes breast cancer in mice.

• Lan MS, Mason A, Coutant R, Chen Q-Y, Vargas A, Rao J, Gomez R, Chalew S, Garry RF, Maclaren NK. HERV-K10s and immune-mediated (type 1) diabetes. Cell 95: 14-16 (1998)
• Plymale DR, Comardalle A, Fermin CD, Ng Tang D, Lewis DF, Garry RF. HIV-1 kills cells using both apoptotic and necrotic pathways. AIDS 13: 1827-1839 (1999)
• Deas JE, Thompson JJ, Fermin CD, Liu LL, Martin D, Garry RF, Gallaher RF, Gallaher WR. Viral induction, transmission and apoptosis among cells infected by a human intracisternal A-type retrovirus. Virus Res 61: 19-27 (1999)
• Karavattathayyil S, Kalkeri G, Gaglio P, Garry RF, Krause J, Dash J, Dash S. Detection of hepatitis C virus RNA sequences in B-cell non-Hodgkin lymphoma. Am J Clin Path 113: 391-398 (2000)
• Kalkeri, G., Garry RF, Fermin CD, Dash S. Hepatitis C virus protein expression induces apoptosis in HepG2 cells. Virology 282: 26-37 (2001)
• Mendez EA, DeSalvo KB, Cao Y, Garry RF, Espinoza LR. Familial erosive arthritis associated with seroreactivity to human intracisternal retroviral particle type I (HIAP-I). Rheumatology 40: 227-228 (2001)
• Qi Z, Kalkeri G, Hanible J, Prabhu R, Bastian F, Garry RF, Dash S. Stem-loop structures (II-IV) of the 5' untranslated sequences are required for the expression of the full-length hepatitis C virus genome. Arch Virol 148, 449-67 (2003)
• Akhter S, Liu H, Prabhu R, DeLuca C, Bastian F, Garry RF, Thung SN, Dash S. Epstein-Barr virus and human hepatocellular carcinoma. Cancer Lett 192, 49-57 (2003)
• Prabhu R, Garry RF, Bastian F, Haque S, Regenstein F, Thung SN, Dash S. Interferon a-2b inhibits negative strand RNA and protein expression from a full-length HCV1a clone. Exp Mol Path 76, 242-252 (2004)

Back to the top

Professor and Chairman of Anesthesiology
Director of Pain Management Center
TCC Associate Member
mgitlin@tulane.edu
Homepage on the Anesthesiology website:
http://www.som.tulane.edu/anes/Faculty_Bios/Gitlin.htm
(504) 988-1916, (504) 988-1743 fax
1430 Tulane Ave., Box SL-4, New Orleans, LA 70112-2699

Melvin C. Gitlin, M.D., FACPM, currently serves as Chairman and Merryl and Sam Israel Professor, Department of Anesthesiology, Tulane University School of Medicine, New Orleans, Louisiana. He also serves as the Director of the Pain Management Center of the Tulane University Health Sciences Center and is an Associate Member of the Tulane Cancer Center. He received his medical degree from the University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, and received his specialty training at the Department of Anesthesiology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania. He is a Diplomate of the American Board of Anesthesiologyand also has been certified in pain management by the Board. He has also been designated a Diplomate of the American Board of Pain Medicine. Dr. Gitlin has a long interest and experience in pain management. He is actively engaged in the practice of anesthesiology and pain medicine and is also involved in research. He lectures at the local, regional, national and international levels. He has been widely published and serves as a reviewer for several journals. He is a member of numerous societies and has been very active in the organized pain community for many years; he has served as chairman of numerous committees and task forces. Among other responsibilities, he currently serves as Immediate Past President and member of the Executive Committee, Board of Directors of the American Academy of Pain Medicine and as Treasurer and member of the Executive Committee of the Board of Directors of the Foundation for Pain Medicine. He is a member of the Examination Council and Credentials Committee of the America Board of Pain Medicine. Dr. Gitlin is a member of the Louisiana State Pain commission and is Past Chairman of the Louisiana State Cancer Pain Initiative. He has served as a founding member of the Board of Directors of the American Alliance of Cancer Pain Initiatives. Dr. Gitlin's experience has encompassed both the private and academic sectors and he has served in government.

• Gitlin MC. Chronic non-cancer pain: An overview of assessment and contemporary management. J La State Med Soc Vol. 151, No. 2. 93-98 (1999)
• Gitlin MC. The Management of Pain. J Pharm Care Pain Symp Cont 7(1):89-90 (1999)
• Gitlin MC. Contracts for opioid administration for the management of chronic pain: A reappraisal. J Pain Symp Mgmt 18:6-8 (1999)
• Gitlin MC. The Pain Clinic Manual. Journal of Pharmaceutical Care in Pain & Symptom Control 8 (4):71-73 (2000)
• Gitlin MC. Meperidine: A perspective on its contemporary use. Journal of Pharmaceutical Care in Pain & Symptom Control. In Press.
• Ferrell BR, Banja J, Dubois MY, Gitlin MC, Hamaty D, Lebovits A. Lipman AG, Lippe P, Livovich JL, Novy D, Sullivan. Ethical Dilemmas in Pain Management. The Journal of Pain (3):172-181 (2001)

Back to the top

Assistant Professor of Chemical Engineering and Biomedical Engineering
TCC Contributing Member in Signaling Research Program
godbey@tulane.edu
(504) 865-5872, (504) 865-5744 fax
300 Lindy Boggs Center, Uptown Campus
6823 St. Charles Avenue, New Orleans, LA 70118-5684
Homepage on the Chemical Engineering website:
http://www.tulane.edu/~ceng/Faculty/godbey/Homex.htm
Courses taught

W.T. Godbey is an Assistant Professor in the Departments of Chemical Engineering and Biomedical Engineering at Tulane University. He received his B.S. in Mathematics from Southern Methodist University in 1988. After a successful period that involved starting his own software design and development company in Dallas, Texas, he joined the fields of science and engineering and earned his Ph.D. as a National Science Foundation Graduate Fellow from the Institute for Biosciences and Bioengineering at Rice University in Houston, Texas, in 2000. From 2000-2003 he was a postdoctoral fellow at Children's Hospital, Boston, and Harvard Medical School. He joined the Tulane faculty in 2003. Gobdey's research interests are centered on gene therapy and the manipulation of cell at the genetic level. He has published several papers on the subjects of cellular processing of non-viral gene delivery agenst and the use of gene therapy for treatment of bladder cancer. His current research interests include the use of gene therapy for carcinoma treatment, controlled release applications for efficient gene delivery, and the use of gene delivery for cellular engineering.

• Godbey WT, Saggau P, Barry MA, Wu KK, Mikos AG. Poly(ethylenimine)-mediated transfection: a new paradigm for non-viral gene delivery. J Biomed Mater Res 51:321-328 (2000)
• Godbey WT, Wu KK, Mikos AG. Poly(ethylenimine)-mediated gene delivery affects endothelials cell function and viability. Biomaterials 22:471-480 (2001)
• Godbey WT, Mikos AG. Recent progress in gene delivery using non-viral transfer complexes. J Controlled Release 72:115-125 (2001)
• Godbey WT, Atala A. In vitro systems for tissue engineering. Ann NY Acad Sci 961:10-26 (2002)
• Godbey WT, Atala A. Directed apoptosis in Cox-2-overexpressing cancer cells through expression-targeted gene delivery. Gene Ther 10:1519-1527 (2003)
• Godbey WT, Hindy S, Sherman ME, Atala A. A novel use of centrifugal force for cell seeding into porous scaffolds. Biomaterials 25:2799-2805 (2004)

Back to the top

Maria da Graça H.Vicente
Professor of Chemistry

Positions and Employment

• 1991 Maitre de Conférence Associé, University of Bourgogne, Dijon, France.
• 1991-1993 Post-doctoral Fellow, University of Geneva, Switzerland.
• 1993 Post-doctoral Fellow, ITQB (Research Institute), Oeiras, Portugal.
• 1993-1998 Assistant Professor, University of Aveiro, Portugal.
• 1996 Visiting Scholar, University of Frankfurt, Germany (1 month).
• 1997 Visiting Scholar, Queen Mary College, London (2 weeks).
• 1997 Visiting Scholar, University of California, Davis (6 months).
• 1998 Research Associate, Department of Chemistry, University of California, Davis.
• 1998 Lecturer, Department of Chemistry, University of California, Davis.
• 1998-2001 Assistant Adjunct Professor, Departments of Chemistry and of Neurological Surgery, University of California, Davis.
• 2001-2006 Associate Professor, Department of Chemistry, Louisiana State University, Baton Rouge, LA
• 2006-present Professor, Department of Chemistry, Louisiana State University, Baton Rouge, LA

Selected Publications:

• K. M. Smith and M. G. H. Vicente. Porphyrins and Related Compounds. In "Houben-Weyl Science of Synthesis", Weinreb, S. M. (Ed.), Georg Thieme Verlag, Stuttgart, 2004, Vol. 17, pg. 1081-1235.
• R. Luguya, L. Jaquinod, F. Fronczek, K. M. Smith and M. G. H. Vicente. Synthesis and Reactions of meso-(p-Nitrophenyl)porphyrins. Tetrahedron 2004, 60 (12), 2757-2763.
• M. G. H. Vicente and K. M. Smith. Porphyrins with Fused Exocyclic Rings. Journal of Porphyrins and Phthalocyanines 2004, 8, 26-42.
• M. De Napoli, S. Nardis, R. Paolesse, M. G. H. Vicente, R. Lauceri and R. Purrello. Hierarchical Porphyrin Self-Assembly in Aqueous Solution. Journal of American Chemical Society 2004, 126 (19), 5934-5935.
• M. G. H. Vicente, V. Gottumukkala, A. Wickramasinghe, M. Anikovsky and M. A. J. Rodgers. Singlet Oxygen Generation and Dark Toxicity of a nido- and a closo-Carboranylporphyrin. Proceedings of SPIE, The International Society for Optical Engineering 2004, 5315, 33-40.
• R. Luguya, F. R. Fronckzek, K. M. Smith and M. G. H. Vicente. Synthesis of Novel Carboranylchlorins with Dual Application in Boron Neutron Capture Therapy (BNCT) and Photodynamic Therapy (PDT). Journal of Applied Radiation and Isotopes 2004, 61, 1117-1123.
• P. Bobadova-Parvanova, Y. Oku, A. Wickramasinghe, R. W. Hall and M. G. H. Vicente. Ab initio and 1H-NMR Study of the Zn(II) Complexes of a nido- and a closo-Carboranylporphyrin. Journal of Porphyrins and Phthalocyanines 2004, 8, 996-1006.
• Conoci, D. M. Guldi, S. Nardis, R. Paolesse, M. Prato, G. Ricciardi, M. G. H. Vicente, I. Zilbermann and L. Valli. Combined Langmuir-Shäfer and Layer-by-Layer Transfer of Fullerene and Porphyrin Derivatives: Deposition, Characterization and Application of the Resulting Films. Chemistry - A European Journal 2004, 10 (24), 6523-6530.
• S. Kazazic, L. Klasinc, S. P. McGlynn, D. Srzic and M. G. H. Vicente. Gas-phase Metallation Reactions of Porphyrins with Metal Monocations. Journal of Physical Chemistry A 2004, 108 (50), 10997-11000.
• V. Gottumukkala, R. Luguya, F. R. Fronczek and M. G. H. Vicente. Synthesis and Cellular Studies of an Octa-anionic 5,10,15,20-Tetra[3,5-(nido-carboranylmethyl)phenyl]porphyrin (H2OCP) for Application in BNCT. Bioorganic and Medicinal Chemistry 2005, 13 (5), 1633-1640.
• E. Hao and M. G. H. Vicente. Expeditious Synthesis of Porphyrin-cobaltacarborane Conjugates. Chemical Communications 2005, 1306-1308.
• C. Poriel, D. Kessel and M. G. H. Vicente. Stability of Tin Etiopurpurin SnET2. Photochemistry and Photobiology 2005, 81(1), 149-153.
• O. Ongayi, V. Gottumukkala, F. R. Fronczek and M. G. H. Vicente. Synthesis and Characterization of a Carboranyl-tetrabenzoporphyrin. Bioorganic and Medicinal Chemistry Letters 2005, 15(6), 1665-1668.
• W. Liu, T. Jensen, F. R. Fronczek, R. Hammer, K. Smith, M. G. H. Vicente. Synthesis and in vitro Studies of Non-aggregated Water-soluble Phthalocyanines. Journal of Medicinal Chemistry 2005, 48, 1033-41.
• J. C. Clark, F. R. Fronczek and M. G. H. Vicente. Novel Carboranylporphyrins for Application in Boron Neutron Capture Therapy (BNCT) of Tumors. Tetrahedron Letters 2005, 46, 2365-2368.
• R. Paolesse, S. Nardis, M. Stefanelli, F. R. Fronczek and M. G. H. Vicente. Hemiporphycene from Expansion of a Corrole Ring. Angewandte Chemie International Edition 2005, 44, 3047-3050.
• R. F. Barth, J. A. Coderre, M. G. H. Vicente and T. E Blue. Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects. Clinical Cancer Research 2005, 11, 3987-4002.
• D. Kessel, M. Conley, M. G. H. Vicente and J. J. Reiners, Jr. Studies on the Sub-cellular Localization of the Porphycene CPO. Photochemistry and Photobiology 2005, 81(3), 569-572.
• R. J. Luguya, F. R. Fronczek, K. M. Smith and M. G. H. Vicente. Carboranylcorroles. Tetrahedron Letters 2005, 46(32), 5365-5368.
• M. Sibrian-Vazquez, T. Jensen, F. Fronczek, R. Hammer, M. G. H. Vicente. Synthesis and Characterization of Positively Charged Porphyrin-peptide Conjugates. Bioconjugate Chemistry 2005, 16, 852-863.
• S. Nardis, R. Paolesse, S. Licoccia, F. R. Fronczek, M. G. H. Vicente, T. K. Shokhireva, S. Cai and F. A. Walker. NMR and Structural Investigations of a Nonplanar Iron Corrolate: Modified Patterns of Spin Delocalization and Coupling in a Slightly Saddled Chloroiron(III) Corrolate Radical. Inorganic Chemistry 2005, 44, 7030-7046.
• W. Liu, F. R. Fronczek, M. G. H. Vicente and K. M. Smith. Diels-Alder Reactions of Pyrrolo[3,4-b]porphyrins. Tetrahedron Letters 2005, 46, 7321-7324.
• E. Hao, T. J. Jensen, B. H. Courtney and M. G. H. Vicente. Synthesis and Cellular Studies of Porphyrin-Cobaltacarborane Conjugates. Bioconjugate Chemistry 2005, 16, 1495-1502.
• K. M. Smith, S. H. Lee and M. G. H. Vicente. Porphyrins with b, b'--Fused Five-membered Rings. Journal of Porphyrins and Phthalocyanines 2005, 9, 769-778.
• J. C. Clark, B. Fabre, F. R. Fronczek and M. G. H. Vicente. Syntheses and Properties of Carboranylpyrroles. Journal of Porphyrins and Phthalocyanines 2005, 9, 803-810.
• O. Ongayi, M. G. H. Vicente, Z. Ou, K. M. Kadish, R. Kumar, F. R. Fronczek and K. M. Smith. Synthesis and Electrochemistry of Undeca-substituted Metallo-benzoylbiliverdins. Inorganic Chemistry 2006, 45, 1463-1470.
• E. Hao, F. R. Fronczek and M. G. H. Vicente. Oxacalixarene-Locked Bis-porphyrins and Higher Oligomers. Journal of Organic Chemistry 2006, 71, 1233-1236.
• V. Gottumukkala, O. Ongayi, D. G. Baker, L. G. Lomax and M. G. H. Vicente. Synthesis, Cellular Uptake and Animal Toxicity of a Tetra(carboranylphenyl)-tetrabenzoporphyrin. Biorganic and Medicinal Chemistry 2006, 14(6), 1871-1879.
• M. W. Renner, M. Miura, M. W. Easson and M. G. H. Vicente. Recent Progress in the Syntheses and Biological Evaluation of Boronated Porphyrins for BNCT. Current Medicinal Chemistry - Anti-Cancer Agents 2006, 6(2), 145-158.
• B. Fabre, J. C. Clark and M. G. H. Vicente. Synthesis and Electrochemistry of Carboranylpyrroles. Toward the Preparation of Electrochemically and Thermally Resistant Conjugated Polymers. Macromolecules 2006, 39. 112-119.
• M. Sibrian-Vazquez, T. J. Jensen, R. P. Hammer and M. G. H. Vicente. Peptide-mediated Cell Transport of Water Soluble Porphyrin Conjugates. Journal of Medicinal Chemistry 2006, 49, 1364-1372.
• D. Kessel, M. G. H. Vicente and J. J. Reiners Jr. Initiation of Apoptosis and Autophagy by Photodynamic Therapy. Lasers in Surgery and Medicine 2006, 38, 482-488.
• M. Sibrian-Vazquez, E. Hao, T. J. Jensen and M. G. H. Vicente. Enhanced Cellular Uptake with a Cobaltacarborane-Porphyrin-HIV-1 Tat 48-60 Conjugate. Bioconjugate Chemistry 2006, 17, 928-934.
• R. Luguya, T. J. Jensen, K. M. Smith and M. G. H. Vicente. Synthesis and Cellular Studies of a Carboranylchlorin for the PDT and BNCT of Tumors. Bioorganic and Medicinal Chemistry 2006, 14, 5890-5897.
• L. Jiao, E. Hao, F. R. Fronczek, M. G. H. Vicente and Kevin M. Smith. Benzoporphyrins via olefin ring-closure metathesis methodology. Chemical Communications 2006, 3900-3902.
• E. Hao, F. R. Fronczek and M. G. H. Vicente. Carborane functionalized pyrroles and porphyrins via the Suzuki cross-coupling reaction. Chemical Communications 2006, 4900-4902.
• R. F. Barth, J. A. Coderre, M. G. H. Vicente, T. E. Blue and S.-I. Miyatake. Boron Neutron Capture Therapy of Brain Tumors. In "High Grade Gliomas: Diagnosis and Treatment", Barnett, G. (Ed.), The Humana Press. Inc., Totowa, NJ, 2006, 431-459.
• M. Sibrian-Vazquez, T. J. Jensen and M. G. H. Vicente. Synthesis and Cellular Studies of PEG-functionalized meso-Tetraphenylporphyrins. Journal of Photochemistry and Photobiology, B: Biology 2007, 86, 9-21.
• M. Sibrian-Vazquez, J. Ortiz, I. V. Nesterova, F. Fernández-Lázaro, A. Sastre-Santos, S. A. Soper, and M. G. H. Vicente. Synthesis and Properties of Cell Targeted Zn(II)-phthalocyanine-peptide Conjugates. Bioconjugate Chemistry 2007, 18, 410-420.
• H. J. H. Wang, L. Jaquinod, M. M. Olmstead, M. G. H. Vicente, K. M. Kadish, Z. Ou, and K. M. Smith. Synthesis, Characterization, and Electrochemical Studies of b,b' - Fused Metallocenoporphyrins. Inorganic Chemistry 2007, 46, 2898-2913.
• M. Sibrian-Vazquez, T. J. Jensen, R. P. Hammer, and M. G. H. Vicente. Synthesis and Cellular Studies of Water Soluble Porphyrin-Peptide Conjugates. Proceedings of SPIE, The International Society for Optical Engineering 2007, 6427, 64270A, pages 1-8.
• L. Jiao, E. Hao, F. R. Fronczek, K. M. Smith and M. G. H. Vicente. Syntheses and Properties of Functionalized Oxacalix[4]arene Porphyrins. Tetrahedron 2007, 63, 4011-4017.
• J. A. Hargus, F. R. Fronczek, M. G. H. Vicente, and K. M. Smith. Mono-(L)-aspartylchlorin-e6. Photochemistry and Photobiology 2007, 83, 1006-1015.
• M. Sibrian-Vazquez, T. J. Jensen, and M. G. H. Vicente. Porphyrin Retinamides: Synthesis and Cellular Studies. Bioconjugate Chemistry 2007, 18, 1185-1193.
• L. Jiao, E. Hao, M. G. H. Vicente and K. M. Smith. An Improved Synthesis of Functionalized 2,2'--Bipyrroles. Journal of Organic Chemistry 2007, 72, 8119-8122.

Back to the top

Carl Austin Gregory, Ph.D.

Assistant Professor, Department of Medicine/Center for Gene Therapy
TCC Program Member
cgregory@tulane.edu
(504) 988-7176, (504) 988-7710 fax
1430 Tulane Ave., SL-99, New Orleans, LA 70112

Biographical Narrative:

Carl Gregory graduated in 1999 with a PhD from the Wellcome Trust Centre for Cell-Matrix Research (University of Manchester, United Kingdom), where he worked in the biochemistry of type X collagen assembly in heritable disorders of the skeleton. There, he was one of the first to propose and substantiate dominant interference as the major cause of the bone development disorder Metaphyseal Chondrodysplasia Type Schmid. Over the past three years,Gregory has studied the role of human mesenchymal stem cells (hMSCs) from bone marrow stroma in bone development and repair in the Tulane University Center for Gene Therapy under the directorship of Darwin Prockop. Carl's recent work has highlighted the importance of Wnt signaling in MSC-mediated bone repair in health and disease. In 2005, Carl was appointed assistant professor in the Department of Medicine at Tulane University Health Sciences Center, where he continues to work in the Center for Gene Therapy.

Selected Publications:

• Gunn WG, Conley A, Prockop DJ, Gregory CA. A crosstalk between myeloma cells and marrow stromal cells stimulated production of DKK1 and IL-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma. Stem Cells, Nov 17, 2005 (epub ahead of print).
• Gregory CA, Singh H, Perry AS, Prockop DJ. Dkk-1 is required for re-entry into the cell cycle of human adult stem cells from bone marrow stroma (hMSCs). J Biol Chem, 278:28067-78, 2003.
• Gregory CA, Perry AS, Reyes E, Conley A, Gunn WG, Prockop DJ. Dkk-1 derived synthetic peptides and lithium chloride for the control and recovery of adult stem cells from bone marrow. J Biol Chem, 280:2309-2323, 2004.
• Gregory CA, Ylostalo J, Prockop DJ. Adult bone marrow stem/progenitor cells (MSCs) are pre-conditioned by micro-environmental "niches" in culture: a two-stage hypothesis for regulation of MSC fate. Sci STKE, 294:37, 2005.

Back to the top

Jeanette Gustat, Ph.D., M.P.H.

Clinical Assistant Professor, Department of Epidemiology
TCC Associate Member
gustat@tulane.edu
(504) 988-1029, (504) 988-1568 fax
1430 Tulane Ave., SL-18, New Orleans, LA 70112

Back to the top